DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Daunorubicin

Daunorubicin

  • A Comparison of Early Intensive Methotrexate/Mercaptopurine With

    A Comparison of Early Intensive Methotrexate/Mercaptopurine With

  • Incidence of Differentiation Syndrome Associated with Treatment

    Incidence of Differentiation Syndrome Associated with Treatment

  • Daunorubicin Hydrochloride Injection Hikma Pharmaceuticals USA Inc

    Daunorubicin Hydrochloride Injection Hikma Pharmaceuticals USA Inc

  • Benefit of Intermediate-Dose Cytarabine-Containing Induction In

    Benefit of Intermediate-Dose Cytarabine-Containing Induction In

  • Acute Lymphoblastic Leukemia (ALL) (Part 1 Of

    Acute Lymphoblastic Leukemia (ALL) (Part 1 Of

  • Acute Myeloid Leukemia (AML) Treatment Regimens

    Acute Myeloid Leukemia (AML) Treatment Regimens

  • Induction Chemotherapy with Standard-Dose Cytarabine

    Induction Chemotherapy with Standard-Dose Cytarabine

  • Daunorubicin Continuous Infusion Induces More Toxicity Than

    Daunorubicin Continuous Infusion Induces More Toxicity Than

  • Adriamycin and Daunorubicin: a Comparison of Antitumor Activities and Tissue Uptake in Mice Following 1

    Adriamycin and Daunorubicin: a Comparison of Antitumor Activities and Tissue Uptake in Mice Following 1

  • Chronic Myelogenous Leukemia (CML) Agents – Unified Formulary

    Chronic Myelogenous Leukemia (CML) Agents – Unified Formulary

  • Cancer Drug Costs for a Month of Treatment at Initial Food

    Cancer Drug Costs for a Month of Treatment at Initial Food

  • Novel Drugs for Older Patients with Acute Myeloid Leukemia

    Novel Drugs for Older Patients with Acute Myeloid Leukemia

  • Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?

    Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?

  • Antitumor Antibiotics

    Antitumor Antibiotics

  • NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2010

    NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2010

  • Vyxeos, INN-Daunorubicin / Cytarabine

    Vyxeos, INN-Daunorubicin / Cytarabine

  • BC Cancer Protocol Summary for First-Line Induction And

    BC Cancer Protocol Summary for First-Line Induction And

  • Derivation of Anthracycline Equivalence to Doxorubicin in Relation to Late Cardiotoxicity: Epirubicin, Idarubicin and Mitoxantrone

    Derivation of Anthracycline Equivalence to Doxorubicin in Relation to Late Cardiotoxicity: Epirubicin, Idarubicin and Mitoxantrone

Top View
  • DRUG NAME: Idarubicin
  • Pharmacy Policy: Trisenox (Arsenic Trioxide)
  • Acute Promyelocytic Leukemia Facts No
  • Experimental Chemotherapy-Induced Skin Necrosis in Swine. Mechanistic Studies of Anthracycline Antibiotic Toxicity and Protection with a Radical Dimer Compound
  • Vincristine and Daunorubicin Administration in an Adolescent During ECMO
  • Daunorubicin and the Heart Such As Hepatic Uptake, Metabolic Conjugation, Secretion, and Br Med J: First Published As 10.1136/Bmj.4.5942.431 on 23 November 1974
  • Synthesis and Evaluation of Daunorubicin-Paclitaxel Dimers
  • How to Order Chemotherapy at Shands at the University of Florida - Inpatient
  • Cytarabine and Daunorubicin (7 Plus 3)
  • DA (3+8)–Cytarabine-Daunorubicin In-Patient Regimen
  • Effects of Vincristine in Combination with Methotrexate and Other Antitumor Agents in Human Acute Lymphoblastic Leukemia Cells in Culture1
  • Combination Effect of Antitumor Agents, Including Doxorubicin
  • New Silicon Compounds As Resistance Modifiers Against Multidrug-Resistant Cancer Cells
  • Hemodialysis Drug Removal
  • Mutagenic and Cytotoxic Activity of Doxorubicin and Daunorubicin Derivatives on Prokaryotic and Eukaryotic Cells N
  • Daunorubicin and Cytarabine) Liposome for Injection, for Cardiac Function That Is Less Than Normal
  • COMMENTARY Treatment of Acute Promyelocytic Leukemia in Children
  • A Randomized Clinical Trial of Daunorubicin and a Combination of Prednisone, Vincristine, 6-Mercaptopurine, and Methotrexate in Adult Acute Nonlymphocytic Leukemia1


© 2024 Docslib.org    Feedback